title: Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm.
abstract: BACKGROUND
  Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation.
  
  
  METHODS
  We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC<7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months.
  
  
  RESULTS
  There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p=.39). There was no difference between the groups in the rate of distant intrahepatic (p=.35) or metastatic progression (p=.48). Surgical patients experienced more complications (p=.004), longer hospitalizations (p<.001), and were more likely to require hospital readmission within 30 days of discharge (p=.03).
  
  
  CONCLUSIONS
  Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC<7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC.
authors.affiliation: Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Eldad
authors.initials: E
authors.lastname: Elnekave
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Erinjeri
authors.forename: Karen T
authors.initials: KT
authors.lastname: Brown
authors.forename: Raymond H
authors.initials: RH
authors.lastname: Thornton
authors.forename: Elena N
authors.initials: EN
authors.lastname: Petre
authors.forename: Majid
authors.initials: M
authors.lastname: Maybody
authors.forename: Mary A
authors.initials: MA
authors.lastname: Maluccio
authors.forename: Meier
authors.initials: M
authors.lastname: Hsu
authors.forename: Constantinos T
authors.initials: CT
authors.lastname: Sofocleous
authors.forename: George I
authors.initials: GI
authors.lastname: Getrajdman
authors.forename: Lynn A
authors.initials: LA
authors.lastname: Brody
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Solomon
authors.forename: William
authors.initials: W
authors.lastname: Alago
authors.forename: Yuman
authors.initials: Y
authors.lastname: Fong
authors.forename: William R
authors.initials: WR
authors.lastname: Jarnagin
authors.forename: Anne M
authors.initials: AM
authors.lastname: Covey
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D017115:Catheter Ablation / Q000401:mortality*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D006498:Hepatectomy / Q000401:mortality*; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D011183:Postoperative Complications; D011379:Prognosis; D012189:Retrospective Studies; D016879:Salvage Therapy; D015996:Survival Rate
references.citation: J Cancer Res Clin Oncol. 2004 Jul;130(7):417-22
references.pmid: 15042359
references.citation: Clin Gastroenterol Hepatol. 2006 Mar;4(3):369-80
references.pmid: 16527702
references.citation: Eur Radiol. 2006 Mar;16(3):661-9
references.pmid: 16228211
references.citation: Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50
references.pmid: 15508101
references.citation: Gastroenterology. 2010 Feb;138(2):513-21, 521.e1-6
references.pmid: 19861128
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Radiology. 2012 Mar;262(3):1022-33
references.pmid: 22357902
references.citation: J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199-202
references.pmid: 14514818
references.citation: J Hepatol. 1999;31 Suppl 1:88-91
references.pmid: 10622567
references.citation: Radiology. 2004 Jan;230(1):300-1; author reply 301-2
references.pmid: 14695404
references.citation: Gastroenterology. 2004 Nov;127(5):1372-80
references.pmid: 15521006
references.citation: Ann Surg. 2008 Apr;247(4):666-73
references.pmid: 18362630
references.citation: Radiology. 2009 Sep;252(3):905-13
references.pmid: 19567647
references.citation: Ann Surg. 2003 Jun;237(6):860-9; discussion 869-70
references.pmid: 12796583
references.citation: Hepatology. 2008 Jan;47(1):82-9
references.pmid: 18008357
references.citation: Lancet. 2012 Mar 31;379(9822):1245-55
references.pmid: 22353262
references.citation: J Vasc Interv Radiol. 2005 Jul;16(7):955-61
references.pmid: 16002503
references.citation: Ann Surg. 2006 Mar;243(3):321-8
references.pmid: 16495695
references.citation: J Clin Oncol. 2009 Mar 20;27(9):1485-91
references.pmid: 19224838
references.citation: Ann Intern Med. 2003 Nov 18;139(10):817-23
references.pmid: 14623619
references.citation: N Engl J Med. 2011 Sep 22;365(12):1118-27
references.pmid: 21992124
references.citation: J Vasc Interv Radiol. 2009 Feb;20(2):217-24
references.pmid: 19097810
references.citation: Hepatology. 2011 Mar;53(3):1020-2
references.pmid: 21374666
references.citation: Ann Surg. 2008 Jul;248(1):1-7
references.pmid: 18580199
references.citation: Ann Surg. 2009 May;249(5):727-34
references.pmid: 19387333
references.citation: Clin Gastroenterol Hepatol. 2007 Apr;5(4):508-12
references.pmid: 17382601
references.citation: Radiology. 2012 Mar;262(3):737-9
references.pmid: 22357877